These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4983374)

  • 21. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intrauterine contraception].
    Lambotte R
    Rev Med Liege; 1984 Apr; 39(7):257-60. PubMed ID: 6729292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hysterosalpingographic changes due to long term effect of intrauterine device.
    Achari K; Kundra VL
    J Obstet Gynaecol India; 1974 Jun; 24(3):293-7. PubMed ID: 12156553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term effects of IUD on the human endometrium. Histologic, histochemical and ultrastructural studies.
    Lee YB; Kim CS; Ro JY; Kwak HM; Song CH
    Yonsei Med J; 1983; 24(2):141-8. PubMed ID: 6679680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loop in the fallopian tube: a case report.
    Sinha GR; Roy KC; Saxena N
    J Obstet Gynaecol India; 1970 Oct; 20(5):676-8. PubMed ID: 12254494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine contraception with the copper-T device. 2. Influence on endometrial acid and alkaline phosphatase, beta-glucuronidase and lactic dehydrogenase activities.
    Hagenfeldt K
    Contraception; 1972 Sep; 6(3):191-206. PubMed ID: 4650669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological characteristics of incrustates of intrauterine contraceptive devices.
    Patai K; Berényi M; Asztalos M
    Acta Morphol Hung; 1986; 34(1-2):3-10. PubMed ID: 3105257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intrauterine T-device and copper-T on in vitro uptake of estradiol-17 beta-6, 7-3H and progesterone-1,2-3H in monkey uterus and cervix.
    Ghosh M; Roy SK
    Contraception; 1976 Mar; 13(3):355-64. PubMed ID: 813938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an intrauterine contraceptive device on urea content of uterine fluid.
    Kar AB; Engineer AD; Dasgupta PR; Srivastava AK
    Am J Obstet Gynecol; 1969 Jun; 104(4):607-8. PubMed ID: 5786713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of the lost IUD.
    Otolorin EO
    Afr J Med Med Sci; 1985; 14(3-4):125-9. PubMed ID: 3004172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.